Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
about
Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanineVisna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosidesAdoptive T-cell therapy for cancer: The era of engineered T cellsBroad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agentAnti-herpes simplex virus activity of 5-substituted 2-pyrimidinone nucleosidesActive cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir)(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replicationActivity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegalovirusesEffect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virusAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell cultureDelayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysisXylotubercidin against herpes simplex virus type 2 in miceEffects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cellsInhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferonsEfficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigsEnhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in miceConditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virusAcyclovir is phosphorylated by the human cytomegalovirus UL97 protein.Crystallization after intravitreal ganciclovir injectionDNA fragments binding CTCF in vitro and in vivo are capable of blocking enhancer activity.Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cellsThe synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin.Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells.Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency.Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblastsComparison of the modes of antiviral action of 2'-nor-deoxyguanosine and its cyclic phosphate, 2'-nor-cyclic GMP.Mutation within the herpes simplex virus DNA polymerase gene conferring resistance to (R)-9-(3,4-dihydroxybutyl)guanine.Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in miceA point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives.Antiviral therapy: current concepts and practicesAcute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.Examination of the roles of transcription factor Sp1-binding sites and an octamer motif in trans induction of the herpes simplex virus thymidine kinase gene.Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus
P2860
Q24646311-CE3DC61C-308D-428D-85CF-ECBB9CE6FE91Q24676814-C3172718-9B72-4088-8A43-BE762FFF9733Q26800611-6A88AB06-CF55-4C58-82DE-3D2EFA8BF7EAQ27477826-56ABA0FA-A778-447B-A31F-5897923240E7Q28342612-D73903F7-D242-4E80-BDF9-DDFF4BE5CD33Q28359826-E14F0369-4C5E-45D5-9750-84DC93625E8CQ28359995-B4D6888B-EEC4-4F6F-A054-4327B0DBB645Q28360393-3D31CB1C-F2F5-4870-B1F7-B4A3785FACA2Q28360564-DBFB1B51-87DD-4C40-BFA5-792902C209B1Q28361902-4CFDB8E3-59F5-4E65-82B2-99A6A1C421C0Q28362122-70E2FDF8-588F-4335-B5CF-E57BA8BCD0C8Q28362158-1B0D7800-ADDE-45CA-B0FB-93F1B487C8DDQ28365697-F1617D73-A674-4AE1-9A8C-EC975F17191EQ28365700-4E6D33A0-B4D5-478B-A8AA-378FC32C0434Q28366907-7E211D3D-459D-4DE0-8530-DAD4023CD518Q28366917-B7F2AE70-485C-45A2-937E-0AF767A88DDAQ30424775-03119FA2-7D69-43EC-929B-8A001CB8D3FDQ30502919-55079423-718D-4B28-9936-562BE5A250C1Q33400808-ADA6F53A-A1CF-4C42-B7A7-498823C38A30Q33928152-0B765841-DE56-4FF6-911A-B78022D5A92FQ33977394-BC44A8DC-6D4A-411E-BBA2-9DFA43140AD5Q34043291-FBEC4FF6-AC2E-43A6-81A7-683AC9DFDE98Q34223098-5861C8EC-9780-478A-B32C-63DBA6200114Q34795512-B077D064-1BA3-4A26-96FB-2B5B700E8ED4Q34885415-A94DF822-5D60-4B8E-8BD6-B84BB7C6C79EQ35537911-D729F465-B46F-481E-BF6B-6BB6716103B3Q35574358-4EB61908-3A3B-4F69-9CEE-B8EE5AB513DCQ35644370-2618A6F1-7F22-4EEF-86B1-2B4BA87985D2Q35646247-702A0B65-D112-41B6-8E32-AD0BAE347032Q35650395-56308F5D-6BEA-4D6A-9FBB-81854DF4560EQ35653248-A79A0AD9-4144-47DE-8760-DBE8E741B432Q35755008-53BDA025-FC61-48D2-B30E-F66E5DC27FDEQ35756914-04EC705C-4139-485E-949F-3E4F3384355AQ35807437-B7B752AD-B543-42C5-BAE7-07301CAADE8FQ36070394-55ECF6FC-68A9-42B7-9DE3-5A95A273D45CQ36748051-754CFE07-BEE7-4C9D-BD2F-4C8E2045AB92Q36754271-D53BD682-FD7A-4225-8FC4-5B105F804D93Q36830830-88E0ABF9-93F8-45BE-B104-7DF4437ACCF6Q36874653-5DC4C61D-177C-46B9-B22A-12E7684C08C7Q36897832-B761E90A-AE80-4F8C-8BBE-8EDD3CAE179A
P2860
Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
description
1983 nî lūn-bûn
@nan
1983 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@ast
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@en
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@nl
type
label
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@ast
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@en
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@nl
prefLabel
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@ast
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@en
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@nl
P2093
P2860
P356
P1476
Anti-herpesvirus activity of t ...... ydroxy-2-propoxymethyl)guanine
@en
P2093
J C Martin
J P Verheyden
T R Matthews
P2860
P304
P356
10.1128/AAC.23.5.676
P407
P577
1983-05-01T00:00:00Z